Baram A, Figer A, Inbar M, Levy E, Peyser M R, Stein Y
Gynecol Oncol. 1985 Nov;22(3):294-301. doi: 10.1016/0090-8258(85)90043-5.
Two hundred twenty-four patients with stage I endometrial carcinoma were treated between the years 1964 and 1978. One hundred and fifteen patients were classified as clinical stage Ia (51.3%) and 109 patients as clinical state Ib (48.7%). For stage Ia the standard treatment protocol was total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH + BSO). In stage Ib disease, preoperative irradiation was performed followed by TAH + BSO after an interval of 4 to 6 weeks. Postoperative irradiation to the pelvis and vaginal vault was given when extrauterine spread was found and in cases of myometrial penetration beyond the inner one-third of the myometrium. At evaluation in May 1983, the rate of disease recurrence in stage Ia was 20% and in stage Ib 9.1%. Five-year survival in stage Ia was 77.3% and 72.4% in stage Ib. Preoperative irradiation was found justified for G3 disregarding the clinical stage, therefore the approach of routine preoperative irradiation in stage Ib is not recommended. The uterine cavity depth was found to be an inaccurate prognostic parameter. According to the data collected in our material the histological grade and myometrial invasion are much better prognostic parameter and should be taken into consideration while planning the treatment regime.
1964年至1978年间,对224例I期子宫内膜癌患者进行了治疗。115例患者被分类为临床Ia期(51.3%),109例患者为临床Ib期(48.7%)。对于Ia期,标准治疗方案是全腹子宫切除术和双侧输卵管卵巢切除术(TAH + BSO)。对于Ib期疾病,先进行术前放疗,间隔4至6周后再行TAH + BSO。当发现子宫外扩散以及肌层浸润超过肌层内三分之一时,对盆腔和阴道穹窿进行术后放疗。在1983年5月的评估中,Ia期疾病复发率为20%,Ib期为9.1%。Ia期的五年生存率为77.3%,Ib期为72.4%。发现对于G3级患者,无论临床分期如何,术前放疗都是合理的,因此不建议对Ib期患者常规进行术前放疗。发现宫腔深度是一个不准确的预后参数。根据我们收集的资料数据,组织学分级和肌层浸润是更好的预后参数,在制定治疗方案时应予以考虑。